Status:
COMPLETED
SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.
Detailed Description
All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for...
Eligibility Criteria
Inclusion
- All patients planned for curatively intended radiotherapy or postoperative radiotherapy
- Recurrent disease
Exclusion
- All patients planned for palliative radiotherapy
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
864 Patients enrolled
Trial Details
Trial ID
NCT01855191
Start Date
June 1 2013
End Date
February 1 2019
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MAASTRO clinic
Maastricht, Netherlands